Sichuan Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy clinical study results published in Annals of Oncology

Kedrion's investigational treatment for Congenital Aceruloplasminemia receives European Orphan Drug Designation

Workit Health Reopens Services in California, Expanding Statewide Access to Virtual Opioid and Alcohol Treatment

Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide

Mendus reports trial follow-up data supporting potential of vididencel in high-risk ovarian cancer

Novo Nordisk submits sNDA to FDA for for higher semaglutide injection dose

Vascular Perfusion Solutions forms collaboration to advance biostasis compounds for organ preservation

SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation

BeOne Medicines' sonrotoclax granted FDA Priority Review for relapsed or refractory mantle cell lymphoma

Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15

AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer

Curasight begins phase 1 trial of uTREAT in glioblastoma

Lunai Bioworks receives first LOI to license next-generation immune cell therapy

Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes

Active Biotech to receive US patent for tasquinimod formulation